Cleared Abbreviated

K032683 - GENESIS II POROUS PLUS HA KNEE SYSTEM (FDA 510(k) Clearance)

Class II Orthopedic device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2003
Decision
47d
Days
Class 2
Risk

K032683 is an FDA 510(k) clearance for the GENESIS II POROUS PLUS HA KNEE SYSTEM. Classified as Prosthesis, Knee, Patello/femorotibial, Semi-constrained, Uncemented, Porous, Coated, Polymer/metal/polymer (product code MBH), Class II - Special Controls.

Submitted by Smith & Nephew, Inc. (Memphis, US). The FDA issued a Cleared decision on October 15, 2003 after a review of 47 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3565 - the FDA orthopedic device regulatory framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Smith & Nephew, Inc. devices

Submission Details

510(k) Number K032683 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 29, 2003
Decision Date October 15, 2003
Days to Decision 47 days
Submission Type Abbreviated
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
75d faster than avg
Panel avg: 122d · This submission: 47d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code MBH Prosthesis, Knee, Patello/femorotibial, Semi-constrained, Uncemented, Porous, Coated, Polymer/metal/polymer
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3565
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MBH Prosthesis, Knee, Patello/femorotibial, Semi-constrained, Uncemented, Porous, Coated, Polymer/metal/polymer

All 141
Devices cleared under the same product code (MBH) and FDA review panel - the closest regulatory comparables to K032683.
Persona the Personalized Knee System (Persona Porous Plasma Spray PPS Femurs)
K253189 · Zimmer, Inc. · Mar 2026
GMK 3D Metal Tibial Tray Extension
K253328 · Medacta International S.A. · Feb 2026
Triathlon® Total Knee System - Triathlon® X3® Medial Stabilized Tibial Bearing Insert
K253637 · Howmedica Osteonics Corp., Dba Stryker Orthopaedics · Feb 2026
Active-V Total Knee System
K253239 · Signature Orthopaedics Pty, Ltd. · Dec 2025
Balanced Knee System TriMax Porous Femoral Components
K253161 · Ortho Development Corp. · Dec 2025
Freedom Metaphyseal Cone Implants (Metaphyseal Cones)
K252777 · Maxx Orthopedics, Inc. · Oct 2025